國立高雄大學圖資館 |

Language: English

Back

Cancer biomarkers in body fluidsprin...

Dakubo, Gabriel D.

Cancer biomarkers in body fluidsprinciples /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Cancer biomarkers in body fluidsby Gabriel D. Dakubo.
Reminder of title:	principles /
Author:	Dakubo, Gabriel D.
Published:	Cham :Springer International Publishing :2016.
Description:	xvi, 299 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	CancerMolecular diagnosis.
Online resource:	http://dx.doi.org/10.1007/978-3-319-01580-4
ISBN:	9783319015804$q(electronic bk.)

Cancer biomarkers in body fluidsprinciples /
Dakubo, Gabriel D.

Cancer biomarkers in body fluidsprinciples /[electronic resource] :by Gabriel D. Dakubo. - Cham :Springer International Publishing :2016. - xvi, 299 p. :ill., digital ;24 cm.

The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the "liquid biopsy" concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.

ISBN: 9783319015804$q(electronic bk.)

Standard No.: 10.1007/978-3-319-01580-4doiSubjects--Topical Terms:

221222
Cancer
--Molecular diagnosis.

LC Class. No.: RC270

Dewey Class. No.: 616.9940756

Cancer biomarkers in body fluidsprinciples /
LDR:02545nmm a2200301 a 4500 001 497166
003 DE-He213
005 20160901122758.0
006 m d
007 cr nn 008maaau
008 170420s2016 gw s 0 eng d
020 $a 9783319015804$q(electronic bk.)
020 $a 9783319015798$q(paper)
024 7 $a 10.1007/978-3-319-01580-4 $2 doi
035 $a 978-3-319-01580-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
082 0 4 $a 616.9940756 $2 23
090 $a RC270 $b .D135 2016
100 1 $a Dakubo, Gabriel D. $3 456557
245 1 0 $a Cancer biomarkers in body fluids $h [electronic resource] : $b principles / $c by Gabriel D. Dakubo.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xvi, 299 p. : $b ill., digital ; $c 24 cm.
520 $a The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the "liquid biopsy" concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.
650 0 $a Cancer $x Molecular diagnosis. $3 221222
650 0 $a Cancer $x Genetic aspects. $3 189391
650 0 $a Biochemical markers. $3 195446
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Human Genetics. $3 273658
650 2 4 $a Oncology. $3 195181
650 2 4 $a Cancer Research. $3 273660
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-01580-4
950 $a Biomedical and Life Sciences (Springer-11642)